A Study of Temodar With Abexinostat (PCI-24781) for Patients With Recurrent Glioma
A Study of Temodar With Abexinostat (PCI-24781) for Patients With Recurrent Glioma
Recruiting · NCT05698524 · Registry updated 2026-09-14Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of Temodar With Abexinostat (PCI-24781) for Patients With Recurrent Glioma | Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, anaplastic astrocytoma, anaplastic oligodendroglioma, astrocytoma (excluding glioblastoma), epithelial neoplasm, glioblastoma, glioma, gliosarcoma, neoplasm, neuroepithelial neoplasm, oligodendroglioma, primitive neuroectodermal tumor | Recruiting | Phase 1 | 2026-09-14 | NCT05698524 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| University of Nebraska | 106 |
| Xynomic Pharmaceuticals, Inc. | 7 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| University of Nebraska Medical Center | Omaha | United States | 397 |